Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Growth Promotion Test Protocol Development – V 2.0

Posted on By

Analytical Method Development: Growth Promotion Test Protocol Development – V 2.0

Standard Operating Procedure for Growth Promotion Test Protocol Development in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/126/2025
Supersedes SOP/AMD/126/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the procedure for developing a protocol for Growth Promotion Tests (GPT) of microbiological culture media to verify its ability to support the growth

of suitable microorganisms, as per pharmacopeial guidelines.

2. Scope

This procedure applies to the Analytical Method Development (AMD) and Microbiology departments for all batches of culture media prepared or procured for microbial limit testing, environmental monitoring, sterility testing, and pathogen detection.

3. Responsibilities

  • Microbiologist: Conducts GPT on media lots and records data accurately.
  • Media Preparer: Prepares the media aseptically and ensures traceability of components.
  • QA Officer: Reviews and verifies GPT protocol adherence and documentation.
  • Head – AMD: Approves final protocol and validates acceptance of GPT results.
See also  Analytical Method Development: SOP for Selection of Chromatographic Conditions - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring proper implementation and documentation of Growth Promotion Test protocols.

5. Procedure

5.1 Media Types and Storage Conditions

  1. Common media to be tested:
    • Tryptic Soy Agar (TSA)
    • Fluid Thioglycollate Medium (FTM)
    • Soybean Casein Digest Medium (SCDM)
    • Sabouraud Dextrose Agar (SDA)
    • MacConkey, Mannitol Salt, Cetrimide, XLD Agar
  2. Store media at 2–8°C (solid) or room temperature (broths) unless otherwise specified.
  3. Assign lot numbers and record preparation details in Annexure-1: Media Preparation and Storage Log.

5.2 Selection and Revival of Microorganisms

  1. Use certified reference strains (e.g., ATCC/MTCC):
    • Staphylococcus aureus (ATCC 6538)
    • Escherichia coli (ATCC 8739)
    • Pseudomonas aeruginosa (ATCC 9027)
    • Bacillus subtilis (ATCC 6633)
    • Candida albicans (ATCC 10231)
  2. Revive cultures on non-selective media and incubate at 30–35°C or 20–25°C depending on organism type.
  3. Prepare inoculum of ≤ 100 CFU/mL by serial dilution in sterile saline or peptone water.
  4. Document strain handling in Annexure-2: Microbial Culture Revival Log.

5.3 Growth Promotion Test Procedure

  1. Label and assign each media lot for GPT testing with organism identification.
  2. Inoculate duplicate plates/tubes of each media with 0.1 mL of appropriate diluted inoculum.
  3. Use uninoculated media as negative controls.
  4. Incubate under conditions suitable for organism recovery:
    • TSA: 30–35°C for 3 days
    • SDA: 20–25°C for 5 days
    • FTM/SCDM: 30–35°C for 14 days
  5. Record growth as ‘acceptable’ if colony morphology and count match expected ranges (typically 50–200% recovery compared to control media).
  6. Log in Annexure-3: GPT Execution Sheet.
See also  Analytical Method Development: SOP for Performing Accuracy Studies in Method Validation - V 2.0

5.4 Acceptance Criteria

  1. Growth must be evident and comparable to a control media batch tested concurrently.
  2. No growth should occur in negative control plates.
  3. Any deviations must be documented and investigated before release of the media batch.

5.5 Documentation and Reporting

  1. Summarize all inoculation conditions, microbial strains, recovery counts, and growth observations.
  2. Attach control data and photographic documentation where applicable.
  3. Prepare final GPT report and submit for QA and department head approval.
  4. Archive in Annexure-4: GPT Summary Report.

6. Abbreviations

  • GPT: Growth Promotion Test
  • TSA: Tryptic Soy Agar
  • FTM: Fluid Thioglycollate Medium
  • CFU: Colony Forming Unit
  • SOP: Standard Operating Procedure

7. Documents

  1. Media Preparation and Storage Log – Annexure-1
  2. Microbial Culture Revival Log – Annexure-2
  3. GPT Execution Sheet – Annexure-3
  4. GPT Summary Report – Annexure-4
See also  Analytical Method Development: SOP for Development of Method for Emulsion Stability - V 2.0

8. References

  • USP <61> and <62> – Microbial Limit Tests
  • USP <71> – Sterility Tests
  • EP 2.6.1 / 2.6.12 / 2.6.13 – Microbiological Methods

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Media Preparation and Storage Log

Media Batch No. Preparation Date Storage Temp Expiry
TSA TSA0525 18/05/2025 2–8°C 18/06/2025

Annexure-2: Microbial Culture Revival Log

Organism Source Revival Date Used For
B. subtilis ATCC 6633 17/05/2025 TSA GPT

Annexure-3: GPT Execution Sheet

Media Organism CFU Inoculated Recovery Result
TSA E. coli 80 76 Pass

Annexure-4: GPT Summary Report

Growth Promotion Test confirmed that all tested media lots supported expected microbial recovery within limits. Negative controls showed no contamination. Media batches TSA0525 and SDA0525 are approved for microbiological use.

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded to include automated ID systems and multiple incubation guidelines Annual Update
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Handling Deviations During Gel Manufacturing – V 2.0
Next Post: Aerosol: SOP for Preparing Equipment Maintenance Schedules – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version